| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | Sr. VP, Business Dev.
1 company
Luu Brendan is a Chief Business Officer at ENANTA PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $588K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | ENTA Enanta Pharmaceuticals Inc | Chief Business Officer | Sell | 1,394 | $14.23 | $19,836.62 | -3.5% | -5.8% | - | |
| Dec 6, 2024 | ENTA Enanta Pharmaceuticals Inc | Chief Business Officer | Sell | 2,283 | $8.06 | $18,400.98 | -6.0% | -10.3% | +82.5% | |
| Dec 5, 2023 | ENTA Enanta Pharmaceuticals Inc | Sr. VP, Business Dev. | Sell | 2,125 | $9.63 | $20,463.75 | -5.5% | +65.3% | -9.9% |